EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A recent update on luteolin: mechanisms and therapeutic implications in cardiac disease

Aysha Javed, Tarique Mahmood, Farogh Ahsan, Aimen Salman, Amrita Shukla, Mohammad Shariq, Abdul Baseer Khan

Journal of Basic and Clinical Physiology and Pharmacology · 2026

DOI: 10.1515/jbcpp-2026-0104 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2026. Verfasst von Aysha Javed und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Integral University, Phase-III, Kursi Road, Barabanki, U.P., India-225302. Hauptthemen laut MEDLINE: Luteolin, Heart Diseases, Cardiotonic Agents. Die Arbeit nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the cardioprotective effects of luteolin, a naturally occurring flavonoid, in mitigating critical pathological processes linked to cardiovascular diseases (CVDs), including oxidative stress, inflammation, mitochondrial dysfunction, and endothelial damage. Luteolin, found in celery, parsley, green peppers, and chamomile tea, exhibits significant cardioprotective properties through various mechanisms. It activates the Nrf2/HO-1 antioxidant pathway, suppresses NF-κB-mediated inflammation, regulates apoptosis, and preserves the functionality of endothelial nitric oxide synthase (eNOS). In preclinical studies involving isoproterenol- and doxorubicin-induced cardiotoxicity, luteolin was shown to reduce oxidative stress, decrease apoptosis, and improve cardiac structure and function. Compared to other flavonoids like quercetin and resveratrol, luteolin demonstrates more potent endothelial-protective effects and a balanced modulation of antioxidant and apoptotic pathways. The diverse actions and natural origin of luteolin make it a promising candidate for CVD prevention and as an adjunctive therapy. Future research should focus on rigorously designed clinical trials to validate its efficacy in heart failure, ischemic injury, and drug-induced cardiotoxicity, thus enhancing its application in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinHeart DiseasesCardiotonic AgentsHumansAnimalsOxidative StressAntioxidantsApoptosisCardiotoxicity

Stichwörter der Autor:innen

Luteolincardio protectioncardiovascular diseases (CVDs)drug-induced cardiotoxicityheart failurepharmacological activities

Substanzen

LuteolinCardiotonic AgentsAntioxidants

Autor:innen und Institutionen

  • College of Pharmacy, Integral University, Phase-III, Kursi Road, Barabanki, U.P., India-225302.
  • Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, U.P., 226026, India.

Zitieren

APA

Javed, A., Mahmood, T., Ahsan, F., Salman, A., Shukla, A., Shariq, M., & Khan, A. B. (2026). A recent update on luteolin: mechanisms and therapeutic implications in cardiac disease. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2026-0104

Vancouver

Javed A, Mahmood T, Ahsan F, Salman A, Shukla A, Shariq M, et al. A recent update on luteolin: mechanisms and therapeutic implications in cardiac disease. Journal of Basic and Clinical Physiology and Pharmacology. 2026. doi:10.1515/jbcpp-2026-0104

BibTeX
@article{Javed2026,
  author = {Javed, Aysha and Mahmood, Tarique and Ahsan, Farogh and Salman, Aimen and Shukla, Amrita and Shariq, Mohammad and Khan, Abdul Baseer},
  title = {A recent update on luteolin: mechanisms and therapeutic implications in cardiac disease},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2026},
  doi = {10.1515/jbcpp-2026-0104}
}
Kostenlos starten →